Tirzepatide for Individuals with Comorbid Obesity and Methamphetamine Use Disorder
Latest Information Update: 10 Feb 2025
Price :
$35 *
At a glance
- Drugs Tirzepatide (Primary)
- Indications Obesity; Substance-related disorders
- Focus Therapeutic Use
- 29 Jan 2025 Status changed from not yet recruiting to recruiting.
- 26 Dec 2024 New trial record